Back

Improving management of patients with atrial fibrillation in the emergency department based on an aggressive rhythm control strategy. The HEROMEDICUS study.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Antiarrhythmic and upstream pharmacological therapy in atrial fibrillation Acute Management ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nikolaos Argyriou

National & Kapodistrian University of Athens Medical School, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Use of class ic antiarrhythmic drugs in atrial fibrillation with structural heart disease: a nationwide cohort study
Assistant Professor J. Jeong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
A multicenter analysis of atrial fibrillation burden reduction with antiarrhythmic drugs in patients with cardiac implantable electronic devices
Doctor S. Schwartz (New York, US)
Abstract Slides Video
Presentation thumbnail
Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials
Doctor M. Casuso Alvarez (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Impact of statin and ezetimibe for the prevention of stroke in patients with atrial fibrillation
Associate Professor K. Lee (Gwangju, KR)
Abstract Slides Video
Presentation thumbnail
The contemporary guideline-directed medical therapy (GDMT) for heart failure is associated with a reduced incidence of new-onset atrial fibrillation in the elderly patients
Doctor Y. Mukai (Fukuoka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Antiarrhythmic and upstream pharmacological therapy in atrial fibrillation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
An aggressive electrophysiologist-guided rhythm control strategy significantly reduces hospital admissions in patients presenting with atrial fibrillation in the emergency department. Data from the HE
thumbnail
Congress Presentation
Impact of rhythm control strategy on outcomes in patients with first diagnosed atrial fibrillation in an 11-year real-world registry
thumbnail
Congress Presentation
Efficacy of smart device heart rhythm monitoring to detect spontaneous conversion to sinus rhythm in patients scheduled for electric cardioversion of atrial fibrillation. Kardiover Study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources